BioCentury
ARTICLE | Company News

Biolex Inc., Epicyte deal

May 10, 2004 7:00 AM UTC

Protein therapeutic developer Biolex acquired antibody company Epicyte. Biolex said the deal combines its Lex System for producing hard-to-make proteins and monoclonal antibodies with Epicyte's techno...